JENNY OLALEYE: Open Payments
NPI 1467039677 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$994 in 25 payments from 12 companies in 2025. Trend: 2023 $637 · 2024 $829 · 2025 $994
Food & beverage: $888Travel & lodging: $106
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $464 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $110 |
| CVRx, Inc. | 1 | $106 |
| Boston Scientific Corporation | 2 | $55 |
| SCPHARMACEUTICALS INC. | 3 | $54 |
| PFIZER INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Abbott Laboratories | 1 | $28 |
Products named: CAMZYOS, LifeVest, Barostim Neo System, FUROSCIX, ELIQUIS, VYNDAQEL, JARDIANCE, SAPIEN 3 Ultra RESILIA.
Industry payments across TX — which companies pay providers there.
